This review assessed the effects of cerebral protection devices during carotid angioplasty and stenting (CAS) in highrisk patients with severe carotid artery disease. The authors concluded that CAS plus cerebral protection may be a safe and effective alternative to carotid endarterectomy. Most of the evidence came from non-randomised studies of apparently variable quality, which severely limits the reliability of the conclusions.
Specific interventions included in the review
Studies that compared carotid endarterectomy (CEA) or CAS without protection to CAS with cerebral protection devices were eligible for inclusion. Studies were excluded if they did not mention the use of cerebral protection devices, discussed only non-filter cerebral protection systems, or involved angioplasty and stenting in vessels other than the carotid artery. Where specified, the cerebral protection devices evaluated were GuardWire, NeuroShield, GuardWire plus, AngioGuard, AngioGuard XP, FilterWire and Parodi AES.
Participants included in the review
Studies of high-risk patients with severe carotid artery disease were eligible for inclusion. Where reported, the primary studies included symptomatic and asymptomatic patients with at least 50% stenosis to at least 80% stenosis.
Outcomes assessed in the review Inclusion criteria were not specified in terms of the outcomes. The review assessed the 30-day incidence of death and stroke (major or minor), 30-day incidence of death, major stroke, minor stroke or myocardial infarction, and adverse effects and procedural or technical success.
How were decisions on the relevance of primary studies made?
Two reviewers independently selected studies using a predefined checklist of inclusion criteria. inclusion criteria for the outcomes were not specified. The strategy undertaken to identify trials was extensive and included considerable efforts to identify unpublished material. No attempts were made to minimise language bias. Methods were used to minimise reviewer errors and bias in the selection of studies, but it was unclear whether similar steps were taken in the validity assessment and data extraction processes. Validity was assessed, but the criteria used to rate studies from good to fair were not reported.
Given the differences between studies, a narrative synthesis was appropriate. However study quality was not taken into account when reporting the results, thus evidence from higher quality studies was not explicitly highlighted. The lack of complete reporting of review methods and the reliance on predominantly non-randomised studies of apparently variable quality limit the reliability of the conclusions.
Implications of the review for practice and research
Practice: The authors stated that the introduction of filter protection devices into routine clinical practice should be controlled (i.e. limiting it to high-risk, high-grade patients; performing procedures at specific sites by experienced specialists adhering to predefined protocols).
Research: The authors did not state any implications for further research. 
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